Fiduciary Group LLC Pfizer Inc Transaction History

Fiduciary Group LLC

$971 Million
Q3 2024

A detailed history of Fiduciary Group LLC transactions in Pfizer Inc stock. As of the latest transaction made, Fiduciary Group LLC holds 86,190 shares of PFE stock, worth $2.3 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

86,190

Previous 93,616 7.93%

Holding current value

$2.3 Million

Previous $2.62 Million 4.77%

% of portfolio

0.26%

Previous 0.29%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$27.7 - $31.39 $205,700 - $233,102	-7,426 Reduced 7.93%	86,190 $2.49 Million
Q2 2024 Aug 08, 2024	SELL	$25.26 - $29.6 $188,591 - $220,993	-7,466 Reduced 7.39%	93,616 $2.62 Million
Q1 2024 May 13, 2024	SELL	$25.89 - $29.73 $125,307 - $143,893	-4,840 Reduced 4.57%	101,082 $2.81 Million
Q4 2023 Feb 05, 2024	SELL	$26.13 - $33.94 $2.88 Million - $3.74 Million	-110,301 Reduced 51.01%	105,922 $3.05 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $565,875 - $661,451	-17,634 Reduced 7.54%	216,223 $7.17 Million
Q2 2023 Jul 27, 2023	SELL	$36.12 - $41.79 $276,245 - $319,609	-7,648 Reduced 3.17%	233,857 $8.58 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $299,482 - $389,881	-7,603 Reduced 3.05%	241,505 $9.85 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $177,136 - $230,606	-4,497 Reduced 1.86%	237,008 $9.67 Million
Q4 2022 Feb 07, 2023	SELL	$41.75 - $54.5 $290,955 - $379,810	-6,969 Reduced 2.72%	249,108 $12.8 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $31,769 - $38,782	-726 Reduced 0.28%	256,077 $12.1 Million
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $157,178 - $186,364	-3,378 Reduced 1.3%	256,803 $13.5 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $311,740 - $386,285	6,814 Added 2.69%	260,181 $12.9 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $45,741 - $67,803	-1,107 Reduced 0.44%	253,367 $15 Million
Q3 2021 Oct 27, 2021	BUY	$39.25 - $50.42 $57,265 - $73,562	1,459 Added 0.58%	254,474 $11.1 Million
Q2 2021 Aug 05, 2021	BUY	$35.91 - $40.68 $49,663 - $56,260	1,383 Added 0.55%	253,015 $11.4 Million
Q1 2021 May 03, 2021	BUY	$33.49 - $37.77 $98,393 - $110,968	2,938 Added 1.18%	251,632 $9.73 Million
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $162,865 - $207,096	4,866 Added 2.0%	248,694 $8.56 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $30,734 - $36,058	-968 Reduced 0.4%	243,828 $8.95 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $144,937 - $175,830	4,812 Added 2.01%	244,796 $8.01 Million
Q1 2020 May 11, 2020	BUY	$27.03 - $38.62 $368,932 - $527,124	13,649 Added 6.03%	239,984 $7.83 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $632,129 - $717,386	19,202 Added 9.27%	226,335 $8.87 Million
Q3 2019 Nov 13, 2019	BUY	$32.49 - $42.13 $338,643 - $439,120	10,423 Added 5.3%	207,133 $7.06 Million
Q2 2019 Aug 05, 2019	BUY	$36.98 - $41.52 $210,822 - $236,705	5,701 Added 2.98%	196,710 $8.52 Million
Q1 2019 May 08, 2019	BUY	$37.5 - $41.2 $78,187 - $85,902	2,085 Added 1.1%	191,009 $8.11 Million
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $241,745 - $275,616	6,284 Added 3.44%	188,924 $8.25 Million
Q3 2018 Oct 18, 2018	BUY	$34.47 - $41.81 $50,464 - $61,209	1,464 Added 0.81%	182,640 $8.05 Million
Q2 2018 Aug 02, 2018	BUY	$32.98 - $35.16 $10,619 - $11,321	322 Added 0.18%	181,176 $6.57 Million
Q1 2018 May 14, 2018	BUY	$31.91 - $37.02 $278,574 - $323,184	8,730 Added 5.07%	180,854 $6.42 Million
Q4 2017 Feb 02, 2018	SELL	$33.26 - $35.29 $80,888 - $85,825	-2,432 Reduced 1.39%	172,124 $6.23 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $5.41 Million - $5.96 Million	174,556	174,556 $6.23 Million

Others Institutions Holding PFE

# of Institutions

3,271

Shares Held

3.63B

Call Options Held

74.3M

Put Options Held

107M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Group LLC with notifications on news.

Account

Fiduciary Group LLC Pfizer Inc Transaction History